Verastem Inc
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
VSTM$8.70+3.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except per share amounts)
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · December 31, · | |||||||
| · 2023 · 2022 | |||||||
| Assets | | | | | | | |
| Current assets: | | | | | | | |
| Cash and cash equivalents | | $77,909 | | $74,933 | | ||
| Short-term investments | | 59,220 | | 12,961 | | ||
| Accounts receivable, net | | | — | | | 31 | |
| Prepaid expenses and other current assets | | 6,553 | | 4,945 | | ||
| Total current assets | | 143,682 | | 92,870 | | ||
| Property and equipment, net | | 37 | | 92 | | ||
| Right-of-use asset, net | | | 1,171 | | | 1,789 | |
| Restricted cash | | | 241 | | | 241 | |
| Other assets | | 4,587 | | 58 | | ||
| Total assets | | $149,718 | | $95,050 | | ||
| Liabilities, convertible preferred stock and stockholders’ equity | | | | | | | |
| Current liabilities: | | | | | | | |
| Accounts payable | | $7,184 | | $4,901 | | ||
| Accrued expenses | | 17,928 | | 14,983 | | ||
| Deferred liabilities | | | 327 | | | 710 | |
| Lease liability, short-term | | 941 | | 794 | | ||
| Convertible senior notes | | | — | | | 275 | |
| Total current liabilities | | 26,380 | | 21,663 | | ||
| Non-current liabilities: | | | | | | ||
| Long-term debt | | | 40,086 | | | 24,526 | |
| Lease liability, long-term | | | 530 | | | 1,470 | |
| Preferred stock tranche liability | | | 4,189 | | | — | |
| Total liabilities | | 71,185 | | 47,659 | | ||
| Convertible preferred stock: | | | | | | | |
| Series B Convertible Preferred Stock, $0.0001 par value; 2,144 and 0 shares designated at December 31, 2023 and December 31, 2022, respectively; 1,200 and 0 shares issued and outstanding at December 31, 2023 and 2022, respectively | | | 21,159 | | | — | |
| Stockholders’ equity: | | | | | | | |
| Preferred Stock, $0.0001 par value; 5,000 shares authorized: | | | | | | | |
| Series A Convertible Preferred Stock, $0.0001 par value; 1,000 shares designated, 1,000 shares issued and outstanding at December 31, 2023 and December 31, 2022 | | | — | | | — | |
| Common stock, $0.0001 par value; 300,000 shares authorized, 25,281 and 16,712 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | | 3 | | 2 | | ||
| Additional paid-in capital | | 882,248 | | 784,912 | | ||
| Accumulated other comprehensive income | | 13 | | — | | ||
| Accumulated deficit | | | (824,890) | | | (737,523) | |
| Total stockholders’ equity | | 57,374 | | 47,391 | | ||
| Total liabilities, convertible preferred stock and stockholders’ equity | | $149,718 | | $95,050 | | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.